|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
for GSTA2 Gene TransactivationNational Research Laboratory, College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Korea
Oltipraz, which has been extensively studied as a cancer chemopreventive agent, promotes phosphatidylinositol 3-kinase-mediated activation of CCAAT/enhancer binding protein-
(C/EBP
). Activated p90 ribosomal S6-kinase-1 (RSK1) phosphorylates major transcription factors, including C/EBP
. This study examined whether oltipraz induces phosphorylation of C/EBP
at specific residues, and if so, whether RSK1 regulates C/EBP
phosphorylation by oltipraz for the GSTA2 gene transactivation. Subcellular fractionation and immunoblot analyses revealed that oltipraz treatment increased the level of C/EBP
phosphorylated at Ser105 in the cytoplasm, which translocated to the nucleus for DNA binding in rat H4IIE cells. Immunoprecipitation-immunoblot, chromatin-immunoprecipitation, and specific mutation analyses revealed that Ser105-phosphorylated C/EBP
recruited the cAMP response element-binding protein binding protein for histone acetylation and transactivation of the GSTA2 gene. The role of RSK1 in Ser105-phosphorylation of C/EBP
by oltipraz and its gene transactivation was evidenced by transfection experiments with dominant-negative mutants of RSK1. In mouse Hepa1c1c, human HepG2 cells, and rat primary hepatocytes, oltipraz induced phosphorylation of C/EBP
at Thr217, Thr266, and Ser105, respectively, via RSK1. The experiment using small-interference RNA of RSK1 confirmed the essential role of RSK1 in the gene expression. Inhibition of PI3-kinase activity prevented oltipraz-inducible Ser105-phosphorylation of rat C/EBP
. Oltipraz treatment led to increases in the catalytic activity and nuclear translocation of RSK1, which was abrogated by PI3-kinase inhibition. In summary, oltipraz induces the phosphorylation of rat C/EBP
at Ser105 (functionally analogous Thr217/266 in mouse and human forms) in hepatocytes, which results in cAMP response element-binding protein-binding protein (CBP) recruitment for the GSTA2 gene transactivation, and the specific C/EBP
phosphorylation is mediated by RSK1 downstream of PI3-kinase.
Address correspondence to: Dr. Sang Geon Kim, College of Pharmacy, Seoul National University, Sillim-dong, Kwanak-gu, Seoul 151-742, South Korea. E-mail: sgk{at}snu.ac.kr
This article has been cited by other articles:
![]() |
Z. Balazs, R. A.S. Schweizer, F. J. Frey, F. Rohner-Jeanrenaud, and A. Odermatt DHEA Induces 11 -HSD2 by Acting on CCAAT/Enhancer-Binding Proteins J. Am. Soc. Nephrol., January 1, 2008; 19(1): 92 - 101. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Y. Lee, C. Y. Han, J. W. Yang, C. Smith, S. K. Kim, E. Y.-H. P. Lee, S. G. Kim, and K. W. Kang Induction of Glutathione Transferase in Insulin-Like Growth Factor Type I Receptor-Overexpressed Hepatoma Cells Mol. Pharmacol., October 1, 2007; 72(4): 1082 - 1093. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Kim and S. J. Lee PI3K, RSK, and mTOR Signal Networks for the GST Gene Regulation Toxicol. Sci., April 1, 2007; 96(2): 206 - 213. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Ko, S. J. Lee, J. W. Kim, J. W. Lim, and S. G. Kim DIFFERENTIAL EFFECTS OF THE OXIDIZED METABOLITES OF OLTIPRAZ ON THE ACTIVATION OF CCAAT/ENHANCER BINDING PROTEIN-{beta} AND NF-E2-RELATED FACTOR-2 FOR GSTA2 GENE INDUCTION Drug Metab. Dispos., August 1, 2006; 34(8): 1353 - 1360. [Abstract] [Full Text] [PDF] |
||||